Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666.

Kenneth W Duncan,Nathalie Rioux,P Ann Boriack-Sjodin,Michael J Munchhof,Lawrence A Reiter,Christina R Majer,Lei Jin,L Danielle Johnston,Elayne Chan-Penebre, Kristy G Kuplast,Margaret Porter Scott,Roy M Pollock,Nigel J Waters,Jesse J Smith,Mikel P Moyer,Robert A Copeland,Richard Chesworth

ACS medicinal chemistry letters（2016）

引用 114|浏览44

暂无评分

摘要

The recent publication of a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) provides the scientific community with in vivo-active tool compound EPZ015666 (GSK3235025) to probe the underlying pharmacology of this key enzyme. Herein, we report the design and optimization strategies employed on an initial hit compound with poor in vitro clearance to yield in vivo tool compound EPZ015666 and an additional potent in vitro tool molecule EPZ015866 (GSK3203591).

查看译文

关键词

Methyltransferase,PRMT5,property based optimization,structure guided design

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要